BioNTech Starts Production at New Covid Vaccine Plant in Germany
This article is for subscribers only.
BioNTech SE started production at a new Covid-19 vaccine factory in Germany, moving closer to its goal of boosting output in Europe by some 750 million doses a year.
The first batch produced at the site in Marburg, north of Frankfurt, enough for 8 million doses, is scheduled for distribution in early April, BioNTech said in a statement.